Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts

  Bladder Cancer

  Free Subscription


1 Abdom Radiol (NY)
1 Actas Urol Esp
1 Am J Case Rep
3 Anticancer Res
1 Arch Esp Urol
1 Asian J Surg
1 BMC Cancer
1 Can J Urol
1 Cancer Lett
1 Cancer Manag Res
1 Clin Genitourin Cancer
1 Eur Urol
1 Genes Chromosomes Cancer
1 Genes Dev
1 J Cell Biochem
1 J Sex Med
1 JAMA Oncol
2 JAMA Surg
2 Jpn J Clin Oncol
1 Med Lett Drugs Ther
1 Mol Clin Oncol
1 N Z Med J
1 Nan Fang Yi Ke Da Xue Xue Bao
1 Nat Rev Urol
5 Oncotarget
1 Pan Afr Med J
2 PLoS One
1 Praxis (Bern 1994)
1 Prog Urol
1 Radiographics
1 Rev Esp Enferm Dig
2 Rev Med Suisse
1 Support Care Cancer
1 Theranostics
2 Transl Androl Urol
1 World J Urol
1 Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Abdom Radiol (NY)

  1. SHAISH H, Newhouse JH
    Split-bolus CT urogram: Is less more?
    Abdom Radiol (NY). 2017;42:2119-2126.
    PubMed     Text format     Abstract available

    Actas Urol Esp

  2. SUBIELA JD, Palou J, Esquinas C, Fernandez Gomez JM, et al
    Clinical usefulness of random biopsies in diagnosis and treatment of non-muscle invasive bladder cancer: Systematic review and meta-analysis.
    Actas Urol Esp. 2017 Nov 20. pii: S0210-4806(17)30196.
    PubMed     Text format     Abstract available

    Am J Case Rep

  3. OKON E, Stearns J, Durgam AK
    Tuberculous Psoas Abscess and Worsening Vascular Aneurysm; All from Bacillus Calmette-Guerin (BCG) Therapy?
    Am J Case Rep. 2017;18:810-812.
    PubMed     Text format     Abstract available

    Anticancer Res

  4. SYRING I, Weiten R, Muller T, Schmidt D, et al
    The Contrasting Role of the Mediator Subunit MED30 in the Progression of Bladder Cancer.
    Anticancer Res. 2017;37:6685-6695.
    PubMed     Text format     Abstract available

  5. MINAMI S, Matsumoto K, Nagashio R, Hagiuda D, et al
    Analysis of Autoantibodies Related to Tumor Progression in Sera from Patients with High-grade Non-muscle-invasive Bladder Cancer.
    Anticancer Res. 2017;37:6705-6714.
    PubMed     Text format     Abstract available

  6. CHEN CC, Huang CP, Tsai YT, Hseih TF, et al
    The Genomic Alterations of 5alpha-Reductases and Their Inhibitor Finasteride's Effect in Bladder Cancer.
    Anticancer Res. 2017;37:6893-6898.
    PubMed     Text format     Abstract available

    Arch Esp Urol

  7. MOLINA ESCUDERO R, Egui Rojo MA, de la Torre J, Paez Borda A, et al
    Back pain after varicocele embolization.
    Arch Esp Urol. 2017;70:623-624.
    PubMed     Text format    

    Asian J Surg

  8. NG KL, Chua CB
    Reiter's syndrome postintravesical Bacillus Calmette-Guerin instillations.
    Asian J Surg. 2017;40:163-165.
    PubMed     Text format     Abstract available

    BMC Cancer

  9. HUEBNER D, Rieger C, Bergmann R, Ullrich M, et al
    An orthotopic xenograft model for high-risk non-muscle invasive bladder cancer in mice: influence of mouse strain, tumor cell count, dwell time and bladder pretreatment.
    BMC Cancer. 2017;17:790.
    PubMed     Text format     Abstract available

    Can J Urol

  10. FREIFELD Y, Lotan Y
    Value of nutrition supplementation prior to cystectomy.
    Can J Urol. 2017;24:8902.
    PubMed     Text format    

    Cancer Lett

  11. CAO R, Wang G, Qian K, Chen L, et al
    TM4SF1 regulates apoptosis, cell cycle and ROS metabolism via the PPARgamma-SIRT1 feedback loop in human bladder cancer cells.
    Cancer Lett. 2017 Nov 23. pii: S0304-3835(17)30733.
    PubMed     Text format     Abstract available

    Cancer Manag Res

  12. DONG F, Shen Y, Gao F, Xu T, et al
    Prognostic value of site-specific metastases and therapeutic roles of surgery for patients with metastatic bladder cancer: a population-based study.
    Cancer Manag Res. 2017;9:611-626.
    PubMed     Text format     Abstract available

    Clin Genitourin Cancer

  13. CAMARGO JA, Passos GR, Ferrari KL, Billis A, et al
    Intravesical Immunomodulatory Imiquimod Enhances Bacillus Calmette-Guerin Downregulation of Nonmuscle-invasive Bladder Cancer.
    Clin Genitourin Cancer. 2017 Nov 7. pii: S1558-7673(17)30335.
    PubMed     Text format     Abstract available

    Eur Urol

  14. CHOI W, McConkey D
    Reply to Joshua A. Linscott, Angela B. Smith, and Jesse D. Sammon's Letter to the Editor re: Woonyoung Choi, Andrea Ochoa, David J. McConkey, et al. Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in The Cancer Genome Atl
    Eur Urol. 2017 Nov 23. pii: S0302-2838(17)30979.
    PubMed     Text format    

    Genes Chromosomes Cancer

  15. TSIKRIKA FD, Avgeris M, Levis PK, Tokas T, et al
    miR-221/222 cluster expression improves clinical stratification of non-muscle invasive bladder cancer (TaT1) patients' risk for short-term relapse and progression.
    Genes Chromosomes Cancer. 2017 Nov 27. doi: 10.1002/gcc.22516.
    PubMed     Text format     Abstract available

    Genes Dev

  16. ELBARBARY RA, Miyoshi K, Hedaya O, Myers JR, et al
    UPF1 helicase promotes TSN-mediated miRNA decay.
    Genes Dev. 2017;31:1483-1493.
    PubMed     Text format     Abstract available

    J Cell Biochem

  17. LIN SR, Yeh HC, Wang WJ, Ke HL, et al
    MiR-193b Mediates CEBPD-Induced Cisplatin Sensitization Through Targeting ETS1 and Cyclin D1 in Human Urothelial Carcinoma Cells.
    J Cell Biochem. 2017;118:1563-1573.
    PubMed     Text format     Abstract available

    J Sex Med

  18. CHAPPIDI MR, Kates M, Sopko NA, Joice GA, et al
    Erectile Dysfunction Treatment Following Radical Cystoprostatectomy: Analysis of a Nationwide Insurance Claims Database.
    J Sex Med. 2017 Apr 28. pii: S1743-6095(17)30427.
    PubMed     Text format     Abstract available

    JAMA Oncol

  19. KOUBA EJ, Cheng L
    Understanding the Genetic Landscape of Small Cell Carcinoma of the Urinary Bladder and Implications for Diagnosis, Prognosis, and Treatment: A Review.
    JAMA Oncol. 2017;3:1570-1578.
    PubMed     Text format     Abstract available

    JAMA Surg

  20. DIAZ DA, Mortazavi A, Lee CT
    A Potential Role for Adjuvant Chemotherapy and Radiotherapy for Patients With High-Risk Bladder Cancer Treated With Cystectomy in the United States.
    JAMA Surg. 2017 Nov 29:e174592. doi: 10.1001/jamasurg.2017.4592.
    PubMed     Text format    

  21. ZAGHLOUL MS, Christodouleas JP, Smith A, Abdallah A, et al
    Adjuvant Sandwich Chemotherapy Plus Radiotherapy vs Adjuvant Chemotherapy Alone for Locally Advanced Bladder Cancer After Radical Cystectomy: A Randomized Phase 2 Trial.
    JAMA Surg. 2017 Nov 29:e174591. doi: 10.1001/jamasurg.2017.4591.
    PubMed     Text format     Abstract available

    Jpn J Clin Oncol

  22. YAMASHITA S, Ito A, Mitsuzuka K, Ioritani N, et al
    Efficacy of early ureteral ligation on prevention of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma: a prospective single-arm multicenter clinical trial.
    Jpn J Clin Oncol. 2017;47:870-875.
    PubMed     Text format     Abstract available

  23. ABE T, Takada N, Kikuchi H, Matsumoto R, et al
    Perioperative morbidity and mortality of octogenarians treated by radical cystectomy-a multi-institutional retrospective study in Japan.
    Jpn J Clin Oncol. 2017;47:755-761.
    PubMed     Text format     Abstract available

    Med Lett Drugs Ther

  24. Three more immune checkpoint inhibitors for advanced bladder cancer.
    Med Lett Drugs Ther. 2017;59:e202-e203.
    PubMed     Text format    

    Mol Clin Oncol

  25. CHEN J, Cui Y, Li P, Liu L, et al
    Expression and clinical significance of androgen receptor in bladder cancer: A meta-analysis.
    Mol Clin Oncol. 2017;7:919-927.
    PubMed     Text format     Abstract available

    N Z Med J

  26. FRASER C, Frizelle F
    A villous adenoma of bladder/urachus origin located in the perineum.
    N Z Med J. 2017;130:73-75.
    PubMed     Text format    

    Nan Fang Yi Ke Da Xue Xue Bao

  27. YU G, Ou ZY, Tao QY, Wan GY, et al
    [Role of lncRNA PTENP1 in tumorigenesis and progression of bladder cancer and the molecular mechanism].
    Nan Fang Yi Ke Da Xue Xue Bao. 2017;37:1494-1500.
    PubMed     Text format     Abstract available

    Nat Rev Urol

    Bladder cancer in 2017: Advancing care through genomics and immune checkpoint blockade.
    Nat Rev Urol. 2017 Nov 28. pii: nrurol.2017.199. doi: 10.1038/nrurol.2017.
    PubMed     Text format    


  29. IMAI-SUMIDA M, Chiyomaru T, Majid S, Saini S, et al
    Silibinin suppresses bladder cancer through down-regulation of actin cytoskeleton and PI3K/Akt signaling pathways.
    Oncotarget. 2017;8:92032-92042.
    PubMed     Text format     Abstract available

  30. WANG F, Wu D, Fu H, He F, et al
    Cofilin 1 promotes bladder cancer and is regulated by TCF7L2.
    Oncotarget. 2017;8:92043-92054.
    PubMed     Text format     Abstract available

  31. WILLIAMS SB, Kamat AM, Mmeje C, Ye Y, et al
    Genetic variants in the inflammation pathway as predictors of recurrence and progression in non-muscle invasive bladder cancer treated with Bacillus Calmette-Guerin.
    Oncotarget. 2017;8:88782-88791.
    PubMed     Text format     Abstract available

  32. HOU T, Zhou L, Wang L, Kazobinka G, et al
    CLCA4 inhibits bladder cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT pathway.
    Oncotarget. 2017;8:93001-93013.
    PubMed     Text format     Abstract available

  33. SUI X, Lei L, Chen L, Xie T, et al
    Inflammatory microenvironment in the initiation and progression of bladder cancer.
    Oncotarget. 2017;8:93279-93294.
    PubMed     Text format     Abstract available

    Pan Afr Med J

  34. SOURAKA TDM, Shi MJ, Meng XY
    [The relationship between tumor recurrence and polymorphisms of hGPX1 and NRAMP1 in superficial bladder cancer patients: a meta-analysis].
    Pan Afr Med J. 2017;27:270.
    PubMed     Text format     Abstract available

    PLoS One

  35. SASAKI N, Ishi K, Kudo N, Nakayama SMM, et al
    Spatial and temporal profile of cisplatin delivery by ultrasound-assisted intravesical chemotherapy in a bladder cancer model.
    PLoS One. 2017;12:e0188093.
    PubMed     Text format     Abstract available

  36. GROMOVA I, Svensson S, Gromov P, Moreira JMA, et al
    Identification of BLCAP as a novel STAT3 interaction partner in bladder cancer.
    PLoS One. 2017;12:e0188827.
    PubMed     Text format     Abstract available

    Praxis (Bern 1994)

  37. TUMA J, Serra A

    Praxis (Bern 1994). 2017;106:899-902.
    PubMed     Text format    

    Prog Urol

  38. ALI P, Lefevre C, Perrouin-Verbe B, Le Normand L, et al
    [Bladder cancer in neurogenic patients: A retrospective study of management and follow-up].
    Prog Urol. 2017 Nov 22. pii: S1166-7087(17)30633.
    PubMed     Text format     Abstract available


  39. POTURALSKI MJ, Magi-Galluzzi C, Liu PS
    Squamous Cell Carcinoma of the Bladder Complicating Schistosomiasis: AIRP Best Cases in Radiologic-Pathologic Correlation.
    Radiographics. 2017;37:500-504.
    PubMed     Text format    

    Rev Esp Enferm Dig

  40. MIR SUBIAS A, Navarro Dourdil M, Charro Calvillo M, Sebastian Domingo JJ, et al
    Combined endoscopic resolution of iatrogenic stricture in an ureterosigmoidostomy.
    Rev Esp Enferm Dig. 2017;109:215-216.
    PubMed     Text format     Abstract available

    Rev Med Suisse

  41. BENACKA M, Benamran DA, Wirth G, Iselin CE, et al
    [Intravesical microwave thermo-chemotherapy for the treatment of non-invasive bladder cancer].
    Rev Med Suisse. 2017;13:2087-2091.
    PubMed     Text format     Abstract available

  42. ADAM SM, Derre L, Jichlinski P, Lucca I, et al
    [Immunotherapy : a revolution in the management of urothelial bladder cancer ?]
    Rev Med Suisse. 2017;13:2074-2078.
    PubMed     Text format     Abstract available

    Support Care Cancer

  43. BANERJEE S, Manley K, Shaw B, Lewis L, et al
    Vigorous intensity aerobic interval exercise in bladder cancer patients prior to radical cystectomy: a feasibility randomised controlled trial.
    Support Care Cancer. 2017 Nov 27. pii: 10.1007/s00520-017-3991.
    PubMed     Text format     Abstract available


  44. ZHANG Q, Zhuang J, Deng Y, Yang L, et al
    miR34a/GOLPH3 Axis abrogates Urothelial Bladder Cancer Chemoresistance via Reduced Cancer Stemness.
    Theranostics. 2017;7:4777-4790.
    PubMed     Text format     Abstract available

    Transl Androl Urol

  45. LUCHINI C, Cheng L
    Predicting the biological behavior of non-muscle-invasive bladder cancer: from histology to molecular taxonomy.
    Transl Androl Urol. 2017;6:987-990.
    PubMed     Text format    

  46. BREYER J
    Improving outcome and prognosis prediction in non-muscle invasive bladder cancer using a gene expression score.
    Transl Androl Urol. 2017;6:991-993.
    PubMed     Text format    

    World J Urol

  47. MATSUMOTO A, Nakagawa T, Kanatani A, Ikeda M, et al
    Preoperative chronic kidney disease is predictive of oncological outcome of radical cystectomy for bladder cancer.
    World J Urol. 2017 Nov 28. pii: 10.1007/s00345-017-2141.
    PubMed     Text format     Abstract available

    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi

  48. LI X, Han X, Yang J, Sun J, et al
    [miR-503-5p inhibits the proliferation of T24 and EJ bladder cancer cells by interfering with the Rb/E2F signaling pathway].
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2017;33:1360-1364.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.